Position in ROIV
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$279,085
+$60,643 QoQ
Shares Held
7,886
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#13
of 31 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in ROIV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Douglas Lane & Associates, LLC holds $94,362,919 across 2 Biotechnology names. ROIV ranks #2 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRNA |
Moderna, Inc.
|
1,343,479 | $94,083,834 | |
| 2 | ROIV |
Roivant Sciences Ltd.
This page
|
7,886 | $279,085 |
All Filings in ROIV
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $279,085 | 7,886 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $218,442 | 7,886 | Shares | Sole | 2026-04-15 | |
| No filing history on record for this holder in this stock. | ||||||